NCT07139899View on ClinicalTrials.gov

Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma

Not yet recruitingOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

September 30, 2027

Conditions
Severe Asthma
Interventions
COMBINATION_PRODUCT

Hyperpolarized Xenon 129

Pulmonary magnetic resonance imaging using hyperpolarized xenon-129 gas as an inhaled contrast agent

Trial Locations (1)

27713

Duke University Medical Center, Durham

Sponsors

Collaborators (1)

Polarean, Inc.
All Listed Sponsors
collaborator

University of Kansas Medical Center

OTHER

collaborator

Polarean, Inc.

INDUSTRY

lead

Bastiaan Driehuys

OTHER